Gilead

The new contract comes as Europe battles a burgeoning COVID wave spearheaded by the Omicron offshoot, BA.5

The health regulator had placed the hold on five cancer trials in January due to an imbalance in suspected and unexpected serious…

This clinical study is the first from Merck and Gilead’s collaboration to develop potential long-acting HIV treatment options

Partnership follows Kite’s investment in Shoreline’s recent Series A financing

Yescarta is the first CAR T-Cell therapy approved for indolent follicular lymphoma

It is authorised or approved for use as a COVID-19 treatment in more than 50 countries

Veklury shortened time to recovery by five days in hospitalised COVID-19 patients

They assured that they will work towards developing innovations to fight the COVID-19 pandemic, ensuring their timely availability…

Gilead Japan will hold marketing authorisation of Jyseleca in Japan while Eisai will be responsible for product distribution

There is no shortage of candidates to help with COVID-19, but what is lacking right now is data on their efficacy